Joseph Miller
Director of Finance/CFO en AURINIA PHARMACEUTICALS INC. .
Fortuna: 3 M $ al 29/02/2024
Perfil
Presently, Joseph M.
Miller is Chief Financial Officer for Aurinia Pharmaceuticals, Inc.
In the past Mr. Miller was Chief Financial Officer & Vice President-Finance at Eppendorf-5 Prime, Inc., Director at Avalo Therapeutics, Inc., Senior Director-Accounting at Qiagen Genomics, Inc. and Vice President-Finance at Sucampo Pharmaceuticals, Inc.
Mr. Miller received an undergraduate degree from Villanova University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
06/03/2024 | 495 928 ( 0.34% ) | 3 M $ | 29/02/2024 |
Cargos activos de Joseph Miller
Empresas | Cargo | Inicio |
---|---|---|
AURINIA PHARMACEUTICALS INC. | Director of Finance/CFO | 27/04/2020 |
Antiguos cargos conocidos de Joseph Miller.
Empresas | Cargo | Fin |
---|---|---|
AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 24/04/2020 |
SUCAMPO PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/04/2018 |
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Comptroller/Controller/Auditor | 01/01/2015 |
Eppendorf-5 Prime, Inc. | Director of Finance/CFO | 01/01/2006 |
Formación de Joseph Miller.
Villanova University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
AURINIA PHARMACEUTICALS INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Eppendorf-5 Prime, Inc. |